PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Demonstrated efficacy in improving symptoms and controlling disease activity [PMID:33123015, PMID:9144848].
Poly-glycosides improved patient outcomes, total remission rates, and reduced 24-h urine protein and relapse events [PMID:38841368].
Clinical studies showed dramatic decreases in Psoriasis Area and Severity Index (PASI) and relief from itching and dryness [PMID:38144417].
Triptolide has shown potential to inhibit tumor cell proliferation, migration, and invasion in lung, pancreatic, and colon cancers [PMID:29970675].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32323812 (2020) — Therapeutic targets of thunder god vine (Tripterygium wilfordii hook) in rheumatoid arthritis (Review). · Molecular medicine reports
- 2.PMID: 42264397 (2026) — Taming the thunder god vine: Antiviral terpenoids from Tripterygium wilfordii. · Fitoterapia
- 3.PMID: 30178091 (2019) — Triptolide, A Potential Autophagy Modulator. · Chinese journal of integrative medicine
- 4.PMID: 20226165 (2010) — Celastrol: Molecular targets of Thunder God Vine. · Biochemical and biophysical research communications
- 5.PMID: 33296090 (2021) — Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment.